PanOptix lens implants hold up well years after cataract surgery, study finds

NCT ID NCT06166901

First seen Mar 24, 2026 · Last updated May 14, 2026 · Updated 5 times

Summary

This study looked at the long-term safety and performance of AcrySof PanOptix trifocal lens implants in 211 people who had them in both eyes for 3 to 5 years. The lenses are used to treat cataracts, astigmatism, and presbyopia. Researchers checked vision and tracked any eye problems or device issues. The study was completed in Spain and did not test any new treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASTIGMATISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Barraquer Ophthalmology Center

    Barcelona, 08021, Spain

  • Clinicas Novovision - Clinica Madrid

    Madrid, 28046, Spain

  • Hospital Arruzafa

    Córdoba, 14012, Spain

  • Hospital Universitari General de Catalunya

    Sabadell, Barcelona, 8205, Spain

  • Institut Catala de la Retina - Sarria

    Barcelona, 8022, Spain

  • Miranza IOA

    Madrid, 28033, Spain

  • Oftalvist Jerez - HLA Puerta del Sur

    Jerez de la Frontera, Cadiz, 11408, Spain

Conditions

Explore the condition pages connected to this study.